BPWM
MESO

BCS Private Wealth Management’s Mesoblast MESO Stock Holding History

BCS Private Wealth Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Hold
16,000
– – 0.07% 165
2025
Q4 		$289K Buy
+16,000
New +$275K 0.1% 146

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BCS Private Wealth Management's MESO Position: Q1 2026 in Review

BCS Private Wealth Management held its Mesoblast (MESO) position steady in Q1 2026 at 16,000 shares worth $246K. The position accounts for 0.07% of the portfolio, ranked #165.

BCS Private Wealth Management first reported a position in MESO in Q4 2025 and has held it in 2 quarters since. The position peaked at $289K in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • BCS Private Wealth Management held 16,000 shares of Mesoblast worth $246K as of Q1 2026.
  • BCS Private Wealth Management left its Mesoblast share count unchanged in Q1 2026.
  • Mesoblast made up 0.07% of BCS Private Wealth Management's portfolio in Q1 2026, its #165 holding.
  • BCS Private Wealth Management first reported a position in Mesoblast in Q4 2025 and has held it in 2 quarters since.
  • BCS Private Wealth Management's Mesoblast position peaked at $289K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on BCS Private Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.